← Eichor
Study identifier: NCT04487249 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Trial of Vision Therapy for Intermittent Exotropia

Condition: Intermittent Exotropia  ·  Sponsor: Southern California College of Optometry at Marshall B. Ketchum University

PhaseNA
Planned participants58
Who can joinAll sexes, 8 Years to 16 Years
Healthy volunteersNo

About this study

The main objective of this randomized trial comparing vision therapy to observation is to determine the short-term effectiveness of vision therapy on distance intermittent exotropia control. The results will help determine whether to proceed to a full-scale, long-term randomized trial.

This description comes directly from the study's public registry record.

Talk to the study team

Angela Chen, OD, MS  ·  714-463-7569  ·  angelachen@ketchum.edu

Always discuss trial participation with your own doctor first.

Locations (6)

University of Alabama in BirminghamBirmingham, Alabama, United StatesRecruiting
Southern California College of Optometry at Marshall B. Ketchum UniversityFullerton, California, United StatesRecruiting
Stanford UniversityStanford, California, United StatesRecruiting
Ohio State UniversityColumbus, Ohio, United StatesRecruiting
Salus UniversityPhiladelphia, Pennsylvania, United StatesRecruiting
Southern College of OptometryMemphis, Tennessee, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04487249